基于网络药理学及实验验证探究芪苈强心胶囊治疗射血分数保留型心衰的作用机制

目的 基于网络药理学及实验验证探讨芪苈强心胶囊治疗射血分数保留型心衰（heart failure with preserved ejection fraction,HFpEF）的作用机制。方法 将44个明确鉴定的芪苈强心胶囊体内代谢物检识有效成分，利用Swisstargetprediction、pharmmapper平台预测化合物靶点，OMIM、DisGenet、GenCard数据库中检索HFpEF疾病靶点；取交集靶点，利用String数据库和Cytoscape 3.7.2软件进行蛋白质-蛋白质相互作用（protein-protein interaction,PPI）和拓扑分析；Metescape平台对共同靶点进行基因本体（gene ontology,GO）功能富集分析及京都基因与基因组百科全书（Kyoto encyclopedia of genes and genomes,KEGG）通路富集分析。构建醋酸脱氧皮质酮（deoxycorticosterone acetate,DOCA）盐敏感型HFpEF大鼠模型，给予沙库巴曲缬沙坦或芪苈强心胶囊进行干预，给药8周后，利用小动物超声成像系统...     

Identification of capsule,biofilm, lateral flagellum,and type IV pili in Vibrio mimicus strains

Vibrio mimicus is a bacterium that causes gastroenteritis; it is closely related to Vibrio cholerae, and can cause acute diarrhea like cholera- or dysentery-type diarrhea. It is distributed worldwide. Factors associated with virulence (such as hemolysins, enterotoxins, proteases, phospholipases, aerobactin, and hemagglutinin) have been identified; however, its pathogenicity mechanism is still unknown. In pathogenic Vibrio species such as V. cholerae, Vibrio. parahaemolyticus and Vibrio vulnificus, capsule, biofilms, lateral flagellum, and type IV pili are structures described as essential for pathogenicity. These structures had not been described in V. mimicus until this work. We used 20 V. mimicus strains isolated from water (6), oyster (9), and fish (5) samples and we were able to identify the capsule, biofilm, lateral flagellum, and type IV pili through phenotypic tests, electron microscopy, PCR, and sequencing. In all tested strains, we observed and identified the presence of capsular exopolysaccharide, biofilm formation in an in vitro model, as well as swarming, multiple flagellation, and pili. In addition, we identified homologous genes to those described in other bacteria of the genus in which these structures have been found. Identification of these structures in V. mimicus is a contribution to the biology of this organism and can help to reveal its pathogenic behavior.     

胃溃疡应用健胃止溃胶囊的疗效探析

目的：对健胃止溃胶囊在胃溃疡治疗中的效果进行探究与分析。方法：对我院2013年7月～2014年7月收治的胃溃疡患者70例进行研究，将之随机分为常规组与改进组并行各自治疗方法，对两组的疗效进行对比分析。结果：两组总有效率及不良反应发生的情况并没有太大差别（P〉0．05），但改进组痊愈率要更加高，且有统计学意义（χ2=5．21，P〉0．05）。结论：健胃止渍胶囊对胃溃疡治疗效果的改善有促进作用，且使用后不良反应发生率有所下降，可在临床上进行推广。     

胶囊内镜对小肠腔内隆起性病变诊断价值

目的探讨胶囊内镜对小肠腔内隆起性病变的诊断价值。方法计算小肠腔内隆起性病变的例数,描述隆起性病变的特点和分析影响因素,初步判断隆起性病变的性质。结果共发现45处隆起,其中22处证实为隆起性病变,约占隆起总数的48.9%,阴性排除率51.1%;胶囊内镜对体积小的隆起性病变观察清晰,体积、位置和小肠液等因素影响观察效果。结论胶囊内镜对隆起性病变具有较高的指导诊断价值。     

养精胶囊通过LncRNA H19调控StAR促进睾酮合成的实验研究※

目的 研究养精胶囊对LncRNA H19调控StAR作用及促进睾酮合成机制。方法 以体外MLTC-1细胞培养为模型，分别加入2 mL的培养基以及终浓度为0.01 mg/mL、0.1 mg/mL、1 mg/mL的养精胶囊水提物，并将其分别作为对照组和养精胶囊低、中、高剂量组，作用24 h。通过ELISA测定细胞T和FT浓度，通过qRT-PCR、Western Blot分别检测养精胶囊对MLTC-1中LncRNA H19 mRNA、StAR mRNA以及StAR蛋白表达的影响。结果 养精胶囊水提物可以显著提高MLTC-1细胞上清T和FT浓度浓度，同时还可以明显促进LncRNA H19 mRNA以及StAR mRNA和蛋白的表达水平，与对照组比较有统计学差异（P<0.05）。结论 养精胶囊可以通过LncRNA H19调控StAR，进而增加睾酮合成。     

海珠益肝胶囊对小鼠免疫性肝损伤的影响

目的:进一步证实海珠益肝胶囊对肝损伤小鼠的保肝降酶作用。方法:来用卡介苗 脂多糖(BCG LPS)造成免疫性肝损伤模型小鼠,观察本品对血清中ALT、AST活力单位、肝脾脏器系数和肝脏病理组织学损伤程度的影响。结果:药物能降低血清中ALT、AST活力单位(P<0.01);减小肝脾肿大及脏器系数(P<0.01);减轻肝组织病理损伤程度。结论:海珠益肝胶囊对BCG LPS所致肝损伤小鼠有明显保肝降酶作用。     

超高效液相色谱－蒸发光散射检测器法测定参松养心胶囊中人参皂苷Rg1和Re含量

目的：建立测定参松养心胶囊中人参皂苷Rg1和Re含量的超高效液相色谱－蒸发光散射检测器（UPLC－ELSD）法。方法采用Waters ACQUITY UPLC BEH C18柱（100 mm ×2.1 mm,1.7μm）为色谱柱,以乙腈－水为流动相(梯度洗脱),流速为0.45 mL/min,柱温为35℃,进样量为2μL,ACQUITY ELSD检测器的漂移管温度为50℃,气体流量为30.0 psi。结果参松养心胶囊中人参皂苷Rg1和Re进样量分别在0.09108~1.1358μg和0.08306~1.03825μg范围内与峰面积线性关系良好,平均加样回收率分别为99.01%和99.25%,RSD分别为0.50%和0.36%（ n=6）。结论与高效液相色谱（HPLC）法相比,UPLC法在不影响分离效果的情况下大大提高了参松养心胶囊中人参皂苷Rg1和Re的分离速度,同时减少了溶剂消耗。UPLC法可作为替代传统HPLC法的一种更方便、快捷、可靠的方法。     

Uso de la cápsula endoscópica en enfermedad inflamatoria intestinal en práctica clínica en España. Resultados de una encuesta nacional

IntroductionSmall bowel capsule endoscopy (SBCE) is a non-invasive diagnostic technique whose use in inflammatory bowel disease (IBD) has spread. A panenteric capsule, PillCam Crohn's (PCC), has recently been developed. We lack information on the availability and use of the CEID and PCC in our environment.MethodsWe conducted an electronic and anonymous survey among the members of the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) [Spanish Working Group on Crohn's Disease and Ulcerative Colitis] and the Asociación Española de Gastroenterología (AEG) [Spanish Association of Gastroenterology], consisting of 37 multiple-choice questions.ResultsOne hundred and fifty members participated, the majority dedicated to IBD (69.3%). 72.8% worked at centres with an IBD unit. 79% had SBCE available at their hospital, 14% referred patients to another centre; 22% had a PCC available, 9% referred patients to another centre. 79.3% of respondents with available SBCE used it in a small percentage of patients with IBD and 15.6% in the majority. The most frequent scenarios were suspicion of Crohn's disease (76.3%), assessment of inflammatory activity (54.7%) and assessment of the extent of the disease (54.7%). More than half (59.7%) preferentially used the Patency capsule to assess intestinal patency. Almost all respondents (99.3%) considered that training resources should be implemented in this technique.ConclusionsSBCE is widely available in Spanish hospitals for the management of IBD, although its use is still limited. There is an opportunity to increase training in this technique, and consequently its use.     

Utilidad de la cápsula endoscópica en el diagnóstico de la enfermedad injerto contra huésped gastrointestinal

Introduction and aimGraft-versus-host disease (GvHD) is a complication of hematopoietic cell transplantation, and the small bowel is one of the main targets in the gastrointestinal tract. Capsule endoscopy is a safe procedure and can be useful in the diagnosis of GvHD. The aim of the present study was to compare the diagnostic yield of capsule endoscopy with the histopathologic findings in GvHD.Materials and methodsA retrospective diagnostic test study included all the patients with suspected GvHD that underwent gastroscopy and colonoscopy, with histopathologic evaluation of the biopsies taken, and capsule endoscopy, within the time frame of July 2015 and July 2019. Capsule endoscopy findings were compared with the histopathologic diagnosis, considered the gold standard.ResultsTwenty-one patients with GvHD (7 [33%] women; 37 ± 11.9 years of age) were included, 20 (95%) of whom had acute GvHD. The median gastric transit time of the capsule was 55 minutes (20-113) and the median small bowel transit time was 261 minutes (238-434). The entire small bowel was visualized through capsule endoscopy in 17 cases (80.95%). The histopathologic findings and capsule endoscopy findings resulted in the diagnosis of GvHD in 17 and 16 cases, respectively. There was agreement between the histopathologic and capsule endoscopy findings in 18 cases (15 positive and 3 negative). Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic yield of capsule endoscopy were 88%, 75%, 94%, 60%, and 85%, respectively.ConclusionsCapsule endoscopy is a safe tool for the diagnosis of GvHD, with high sensitivity and positive predictive value, as well as moderate agreement with histopathologic findings.     

红景天胶囊对兔急性心肌缺血再灌注损伤的保护作用

目的 研究红景天胶囊对兔急性心肌缺血再灌注损伤的的影响及其保护机制.方法 实验选取10只健康日本大耳白兔为假手术组,另取20只随机分为模型组及红景天组,2组均采用手术结扎左侧冠状动脉前降支30 min后再灌注60min,反复3次以造成急性心肌缺血再灌注损伤动物模型.术后3组动物均灌胃给药,测定治疗前及治疗1、2周总超氧化物歧化酶(T-SOD)、一氧化氮(NO)、血管内皮素-1(ET-1)、血清丙二醛(MDA)、血清肌酸激酶(CK)、白细胞介素-6(IL-6)水平,记算治疗2周后兔心肌缺血梗死率(％)等指标,并分析红景天胶囊对兔急性心肌缺血再灌注损伤的影响.结果 红景天胶囊明显提高红景天组兔NO含量及T-SOD活性,降低ET-1及血清MDA、CK、IL-6水平,减少急性心肌缺血梗死率,与模型组比较,差异均有统计学意义(P＜0.05).结论 红景天胶囊可提高兔急性心肌缺血再灌注后T-SOD及NO活性,促进氧自由基清除酶清除氧自由基、降低心肌缺血时脂质过氧化,进而改善再灌注损伤后受损血管内皮并维持其正常功能,增加心肌组织耐缺氧能力,对急性心肌缺血再灌注具有保护作用.